Literature DB >> 19054805

Inhibition of the 20S proteosome by a protein proteinase inhibitor: evidence that a natural serine proteinase inhibitor can inhibit a threonine proteinase.

Kimihiko Yabe1, Takehiko Koide.   

Abstract

The 20S proteasome (20S) is an intracellular threonine proteinase (Mr 750,000) that plays important roles in many cellular regulations. Several synthetic peptide inhibitors and bacteria-derived inhibitors such as lactacystin and epoxomicin have been identified as potent proteasome inhibitors. However, essentially no protein proteinase inhibitor has been characterized. By examining several small size protein proteinase inhibitors, we found that a well-known serine proteinase inhibitor from bovine pancreas, basic pancreatic trypsin inhibitor (BPTI), inhibits the 20S in vitro and ex vivo. Inhibition of the 20S by BPTI was time- and concentration-dependent, and stoichiometric. To inhibit the 20S activity, BPTI needs to enter into the interior of the 20S molecule. The molar ratio of BPTI to the 20S in the complex was estimated as approximately six BPTI to one 20S, thereby two sets of three peptidase activities (trypsin-like, chymotrypsin-like and caspase-like) of the 20S were all inhibited. These results indicate that an entrance hole to the 20S formed by seven alpha-subunits is sufficiently large for BPTI to enter. This report is essentially the initial description of the inhibition of a threonine proteinase by a protein serine proteinase inhibitor, suggesting a common mechanism of inhibition between serine and threonine proteinases by a natural protein proteinase inhibitor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19054805     DOI: 10.1093/jb/mvn160

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

1.  Roseltide rT7 is a disulfide-rich, anionic, and cell-penetrating peptide that inhibits proteasomal degradation.

Authors:  Antony Kam; Shining Loo; Jing-Song Fan; Siu Kwan Sze; Daiwen Yang; James P Tam
Journal:  J Biol Chem       Date:  2019-11-14       Impact factor: 5.157

2.  Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodes.

Authors:  Britta Stadelmann; Denise Aeschbacher; Cristina Huber; Markus Spiliotis; Joachim Müller; Andrew Hemphill
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

3.  Inhibition of human and yeast 20S proteasome by analogues of trypsin inhibitor SFTI-1.

Authors:  Dawid Dębowski; Michał Pikuła; Marta Lubos; Paulina Langa; Piotr Trzonkowski; Adam Lesner; Anna Łęgowska; Krzysztof Rolka
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.